Long term results of heart transplantation in patients with amyloid heart disease

Heart

Volumn 85, Issue 2, 2001, Pages 202-207

  Dubrey, S W ^a   Burke, M M ^a   Khaghani, A ^a   Hawkins, P N ^b   Yacoub, M H ^a   Banner, N R ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Amyloid heart disease; Heart failure; Heart transplantation

Indexed keywords

IODINE 123; SERUM AMYLOID P;

ADULT; ARTICLE; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART AMYLOIDOSIS; HEART TRANSPLANTATION; HUMAN; MALE; PALLIATIVE THERAPY; PRIORITY JOURNAL; SCINTIGRAPHY; STAGING; SURGICAL MORTALITY; SURVIVAL; TREATMENT OUTCOME;

EID: 0034769059     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.85.2.202     Document Type: Article

References (30)

1. Amyloid fibril proteins: Proof of homology with immunoglobulin light chains by sequence analyses
2. The systemic amyloidosis
3. Response rates and survival in primary systemic amyloidosis
4. Primary (AL) cardiac amyloidosis: Symptoms, signs and non-invasive investigations in 232 patients
5. Inherited amyloidosis
6. Apolipoprotein A1 mutation Arg-60 causes autosomal dominant amyloidosis
7. Human lysozyme gene mutations cause hereditary systemic amyloidosis
8. Hereditary renal amyloidosis associated with a mutant fibrinogen α-chain
9. Successful intermediate-term outcome for patients with cardiac amyloidosis undergoing heart transplantation: Results of a multicenter survey
10. Progression of systemic disease and reduced long term survival in patients with cardiac amyloidosis undergoing heart transplantation
11. 123I-labelled serum amyloid P component
12. Imaging amyloidosis with radiolabelled SAP
13. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases
14. Echocardiographic assessment of the evolution of amyloid heart disease: A study with familial amyloid polyneuropathy
15. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart rejection study group
16. Cardiac transplantation for AL amyloidosis; good quality of life is possible for several years
17. The registry of the International Society for Heart and Lung Transplantation: Thirteenth official report - 1996
18. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the committee on heart failure and cardiac transplantation of the Council on Clinical Cardiology, American Heart Association
19. Heart transplantation for cardiac amyloidosis: Successful one year outcome despite recurrence of the disease
20. Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survival
21. Effectiveness of cardiac transplantation for primary (AL) cardiac amyloidosis
22. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo
23. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis
24. Treatment of amyloidosis
25. Pathogenesis, diagnosis and treatment of systemic amyloidosis
26. Dose-intensive melphalan with blood stem-cell support for the treatment of AL amyloidosis: One year follow up in five patients
27. Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: A report of 21 patients
28. Dose-intensive melphalan with blood stem-cell support for the treatment of AL amyloidosis: Survival and responses in 25 patients
29. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy